Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractAlterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury    Next AbstractHow integration of global omics-data could help preparing for pandemics - a scent of influenza »

BMC Pulm Med


Title:Exhaled breath profiling for diagnosing acute respiratory distress syndrome
Author(s):Bos LD; Schultz MJ; Sterk PJ;
Address:"Department of Intensive Care Medicine, Academic Medical Center, University of Amsterdam, Meibergdreef 9, G3-228, 1105 AZ Amsterdam, The Netherlands. l.d.bos@amc.uva.nl"
Journal Title:BMC Pulm Med
Year:2014
Volume:20140426
Issue:
Page Number:72 -
DOI: 10.1186/1471-2466-14-72
ISSN/ISBN:1471-2466 (Electronic) 1471-2466 (Linking)
Abstract:"BACKGROUND: The acute respiratory distress syndrome (ARDS) is a common, devastating complication of critical illness that is characterized by pulmonary injury and inflammation. The clinical diagnosis may be improved by means of objective biological markers. Electronic nose (eNose) technology can rapidly and non-invasively provide breath prints, which are profiles of volatile metabolites in the exhaled breath. We hypothesized that breath prints could facilitate accurate diagnosis of ARDS in intubated and ventilated intensive care unit (ICU) patients. METHODS: Prospective single-center cohort study with training and temporal external validation cohort. Breath of newly intubated and mechanically ventilated ICU-patients was analyzed using an electronic nose within 24 hours after admission. ARDS was diagnosed and classified by the Berlin clinical consensus definition. The eNose was trained to recognize ARDS in a training cohort and the diagnostic performance was evaluated in a temporal external validation cohort. RESULTS: In the training cohort (40 patients with ARDS versus 66 controls) the diagnostic model for ARDS showed a moderate discrimination, with an area under the receiver-operator characteristic curve (AUC-ROC) of 0.72 (95%-confidence interval (CI): 0.63-0.82). In the external validation cohort (18 patients with ARDS versus 26 controls) the AUC-ROC was 0.71 [95%-CI: 0.54 - 0.87]. Restricting discrimination to patients with moderate or severe ARDS versus controls resulted in an AUC-ROC of 0.80 [95%-CI: 0.70 - 0.90]. The exhaled breath profile from patients with cardiopulmonary edema and pneumonia was different from that of patients with moderate/severe ARDS. CONCLUSIONS: An electronic nose can rapidly and non-invasively discriminate between patients with and without ARDS with modest accuracy. Diagnostic accuracy increased when only moderate and severe ARDS patients were considered. This implicates that breath analysis may allow for rapid, bedside detection of ARDS, especially if our findings are reproduced using continuous exhaled breath profiling. TRIAL REGISTRATION: NTR2750, registered 11 February 2011"
Keywords:Aged Breath Tests Female Humans Male Middle Aged Prospective Studies Respiratory Distress Syndrome/*diagnosis Volatile Organic Compounds/analysis;
Notes:"MedlineBos, Lieuwe D J Schultz, Marcus J Sterk, Peter J eng Research Support, Non-U.S. Gov't England 2014/04/29 BMC Pulm Med. 2014 Apr 26; 14:72. doi: 10.1186/1471-2466-14-72"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 29-11-2024